Skip to main content
. 2022 Feb 10;14(2):393. doi: 10.3390/pharmaceutics14020393

Figure 3.

Figure 3

Profiles of the cell viability (MTT assay) after incubation with CuD metallodendrons and temozolomide (TMZ). NTC—non-treated control. Data are presented as mean ± S.D. * p < 0.05, ** p < 0.01 CuD vs. AuD; # p < 0.05, ## p < 0.01 CuD vs. TMZ.